Arboretum Ventures

Portfolio Co Investors 2026 for Arboretum Ventures: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Arboretum Ventures accounts for 16 tracked companies with verified cap-table data, 16 of which disclose round sizes totalling $2B. The median disclosed raise is $80M, and the largest is EQRx at $750M, ahead of Francis Medical ($160M) and Endogenex ($138M).

The names that recur most often on these co-invested cap tables are Arboretum Ventures (16 companies), Orlando Health Ventures (2 companies), Hatteras Venture Partners (2 companies), HealthQuest Capital (2 companies), 5AM Ventures (2 companies), Lightstone Ventures (2 companies). By latest disclosed round, the market skews Series C (6), Series B (3), Series D (3), Growth (3).

Best funded Arboretum Ventures companies

  1. EQRx — $750M (latest: Series B)
  2. Francis Medical — $160M (latest: Series C)
  3. Endogenex — $138M (latest: Series C)
  4. Delphinus Medical Technologies — $130M (latest: Series D)
  5. RareCyte — $120M (latest: Growth)
  6. Reprieve Cardiovascular — $103M (latest: Series B)
  7. Koya Medical — $100M (latest: Other Equity)
  8. Convergent Dental — $80M (latest: Growth)
  9. Orasis Pharmaceuticals — $78M (latest: Series D)
  10. AtaCor Medical — $62M (latest: Series C)
  11. Allay Therapeutics — $60M (latest: Series C)
  12. Interventional Pain Management — $58M (latest: Series D)
  13. ViaLase — $40M (latest: Series C)
  14. Flosonics — $39M (latest: Series C)
  15. Xinma Bio — $21M (latest: Series B)

Arboretum Ventures — related firms and companies (56)

Arboretum Ventures alternatives · All research reports